And this would be the much needed, or required expertise.
Cord Blood America (CBAI:$0.0094,$-0.0002,-2.08%) will grant to AXM a license to use its proprietary technology and know-how for the processing and storage of cord blood and CBAI will provide consulting and training.
I think some of China's current policies are the result of some of the " corruption " that plagued the cord blood industry in not only China but Korea as well. I'm sure their were other countries as well...not picking on Asia here..